P. Libby, P. Ridker, and G. Hansson, Inflammation in Atherosclerosis, Journal of the American College of Cardiology, vol.54, issue.23, pp.2129-2138, 2009.
DOI : 10.1016/j.jacc.2009.09.009

G. Hansson, Inflammation, Atherosclerosis, and Coronary Artery Disease, New England Journal of Medicine, vol.352, issue.16, pp.1685-1695, 2005.
DOI : 10.1056/NEJMra043430

F. Hellenthal, W. Buurman, W. Wodzig, and G. Schurink, Biomarkers of abdominal aortic aneurysm progression. Part 2: inflammation, Nature Reviews Cardiology, vol.49, issue.8, pp.543-552, 2009.
DOI : 10.1038/nrcardio.2009.102

G. Caligiuri, G. Paulsson, A. Nicoletti, A. Maseri, and G. Hansson, Evidence for Antigen-Driven T-Cell Response in Unstable Angina, Circulation, vol.102, issue.10, pp.1114-1119, 2000.
DOI : 10.1161/01.CIR.102.10.1114

G. Caligiuri, D. Stahl, S. Kaveri, T. Irinopoulous, F. Savoie et al., Autoreactive antibody repertoire is perturbed in atherosclerotic patients investigation, Laboratory, vol.83, pp.939-947, 2003.

G. Caligiuri and A. Nicoletti, Tregs and human atherothrombotic diseases: toward a clinical application? Arteriosclerosis, thrombosis, and vascular biology, pp.1679-1681, 2010.

Z. Mallat, S. Taleb, H. Ait-oufella, and A. Tedgui, The role of adaptive T cell immunity in atherosclerosis, The Journal of Lipid Research, vol.50, issue.Supplement, pp.364-369, 2009.
DOI : 10.1194/jlr.R800092-JLR200

J. Newton, C. Buckley, E. Jones, and D. Simmons, Residues on Both Faces of the First Immunoglobulin Fold Contribute to Homophilic Binding Sites of PECAM-1/CD31, Journal of Biological Chemistry, vol.272, issue.33, pp.20555-20563, 1997.
DOI : 10.1074/jbc.272.33.20555

P. Newman, Switched at birth: a new family for PECAM-1, Journal of Clinical Investigation, vol.103, issue.1, pp.5-9, 1999.
DOI : 10.1172/JCI5928

P. Newman and D. Newman, Signal Transduction Pathways Mediated by PECAM-1: New Roles for an Old Molecule in Platelet and Vascular Cell Biology, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.6, pp.953-964, 2003.
DOI : 10.1161/01.ATV.0000071347.69358.D9

S. Brown, I. Heinisch, E. Ross, K. Shaw, C. Buckley et al., Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment, Nature, vol.66, issue.6894, pp.200-203, 2002.
DOI : 10.1074/jbc.275.8.5987

M. Wong, J. Hayball, P. Hogarth, and D. Jackson, The inhibitory co-receptor, p.1

S. Falati, S. Patil, P. Gross, M. Stapleton, G. Merrill-skoloff et al., Platelet PECAM-1 inhibits thrombus formation in vivo, Blood, vol.107, issue.2, pp.535-541, 2006.
DOI : 10.1182/blood-2005-04-1512

G. Caligiuri, E. Groyer, J. Khallou-laschet, A. H. Zen, A. Sainz et al., Reduced Immunoregulatory CD31+ T Cells in the Blood of Atherosclerotic Mice With Plaque Thrombosis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.25, issue.8, pp.1659-1664, 2005.
DOI : 10.1161/01.ATV.0000172660.24580.b4

G. Caligiuri, P. Rossignol, J. P. Groyer, E. Mouradian, D. Urbain et al., Reduced Immunoregulatory CD31+ T Cells in Patients With Atherosclerotic Abdominal Aortic Aneurysm, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, issue.3, pp.618-623, 2006.
DOI : 10.1161/01.ATV.0000200380.73876.d9

G. Fornasa, E. Groyer, M. Clement, J. Dimitrov, C. Compain et al., TCR Stimulation Drives Cleavage and Shedding of the ITIM Receptor CD31, The Journal of Immunology, vol.184, issue.10, pp.5485-5492, 2010.
DOI : 10.4049/jimmunol.0902219

URL : https://hal.archives-ouvertes.fr/inserm-00512366

F. Montecucco, A. Pende, and F. Mach, The Renin-Angiotensin System Modulates Inflammatory Processes in Atherosclerosis: Evidence from Basic Research and Clinical Studies, Mediators of Inflammation, vol.148, issue.1, p.752406, 2009.
DOI : 10.1007/s00109-008-0338-y

T. Guzik, N. Hoch, K. Brown, L. Mccann, A. Rahman et al., Role of the T cell in the genesis of angiotensin II???induced hypertension and vascular dysfunction, The Journal of Experimental Medicine, vol.15, issue.10, pp.2449-2460, 2007.
DOI : 10.1161/01.HYP.0000235682.47673.ab

Y. Wang, H. Ait-oufella, O. Herbin, P. Bonnin, B. Ramkhelawon et al., TGF-?? activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II???infused mice, Journal of Clinical Investigation, vol.120, issue.2, pp.422-432, 2010.
DOI : 10.1172/JCI38136DS1

A. Daugherty, M. Manning, and L. Cassis, Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E???deficient mice, Journal of Clinical Investigation, vol.105, issue.11, pp.1605-1612, 2000.
DOI : 10.1172/JCI7818

K. Saraff, F. Babamusta, L. Cassis, and A. Daugherty, Aortic Dissection Precedes Formation of Aneurysms and Atherosclerosis in Angiotensin II-Infused, Apolipoprotein E-Deficient Mice, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.9, pp.1621-1626, 2003.
DOI : 10.1161/01.ATV.0000085631.76095.64

H. Uchida, F. Kristo, D. Rateri, H. Lu, R. Charnigo et al., Total lymphocyte deficiency attenuates AngII-induced atherosclerosis in males but not abdominal aortic aneurysms in apoE deficient mice, Atherosclerosis, vol.211, issue.2, pp.399-403, 2010.
DOI : 10.1016/j.atherosclerosis.2010.02.034

S. Crowley, Y. Song, E. Lin, R. Griffiths, H. Kim et al., Lymphocyte responses exacerbate angiotensin II-dependent hypertension, AJP: Regulatory, Integrative and Comparative Physiology, vol.298, issue.4, pp.1089-1097, 2010.
DOI : 10.1152/ajpregu.00373.2009

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422347

P. Marvar, S. Thabet, T. Guzik, H. Lob, L. Mccann et al., Central and Peripheral Mechanisms of T-Lymphocyte Activation and Vascular Inflammation Produced by Angiotensin II-Induced Hypertension, Circulation Research, vol.107, issue.2, pp.263-270, 2010.
DOI : 10.1161/CIRCRESAHA.110.217299

Y. Chen, P. Schlegel, N. Tran, D. Thompson, J. Zehnder et al., Administration of a CD31-derived peptide delays the onset and significantly increases survival from lethal graftversus-host disease, Blood, vol.89, pp.1452-1459, 1997.

K. Shimada and Y. Yazaki, Binding Sites for Angiotensin II in Human Mononuclear Leucocytes1, The Journal of Biochemistry, vol.84, issue.4, pp.1013-1015, 1978.
DOI : 10.1093/oxfordjournals.jbchem.a132183

B. Tieu, C. Lee, H. Sun, W. Lejeune, R. A. Ju et al., An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice, Journal of Clinical Investigation, vol.119, issue.12, pp.3637-3651, 2009.
DOI : 10.1172/JCI38308DS1

L. Ma, C. Mauro, G. Cornish, J. Chai, D. Coe et al., Ig gene-like molecule CD31 plays a nonredundant role in the regulation of T-cell immunity and tolerance, Proceedings of the National Academy of Sciences, vol.107, issue.45, pp.19461-19466, 2010.
DOI : 10.1073/pnas.1011748107

H. Adler, S. Kubsch, E. Graulich, S. Ludwig, J. Knop et al., Activation of MAP kinase p38 is critical for the cell-cycle-controlled suppressor function of regulatory T cells, Blood, vol.109, issue.10, pp.4351-4359, 2007.
DOI : 10.1182/blood-2006-09-047563

S. Van-leuven, J. Kastelein, A. Allison, M. Hayden, and E. Stroes, Mycophenolate mofetil (MMF): Firing at the atherosclerotic plaque from different angles?, Cardiovascular Research, vol.69, issue.2, pp.341-347, 2006.
DOI : 10.1016/j.cardiores.2005.09.018

N. Sasaki, T. Yamashita, M. Takeda, M. Shinohara, K. Nakajima et al., Oral Anti-CD3 Antibody Treatment Induces Regulatory T Cells and Inhibits the Development of Atherosclerosis in Mice, Circulation, vol.120, issue.20, pp.1996-2005, 2009.
DOI : 10.1161/CIRCULATIONAHA.109.863431

S. Steffens, F. Burger, G. Pelli, Y. Dean, G. Elson et al., Short-Term Treatment With Anti-CD3 Antibody Reduces the Development and Progression of Atherosclerosis in Mice, Circulation, vol.114, issue.18, pp.1977-1984, 2006.
DOI : 10.1161/CIRCULATIONAHA.106.627430

H. Ait-oufella, O. Herbin, J. Bouaziz, C. Binder, C. Uyttenhove et al., B cell depletion reduces the development of atherosclerosis in mice, The Journal of Experimental Medicine, vol.207, issue.8, pp.1579-1587, 2010.
DOI : 10.1161/01.CIR.102.24.2919